Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

Wednesday’s trading has closed, but AMGN is being traded in the after-hours session. After-Hours quote »
171.47
Delayed Data
As of 3:59pm ET
 -1.27 / -0.74%
Today’s Change
122.25
Today|||52-Week Range
174.80
+7.65%
Year-to-Date

Today’s Trading

Previous close172.74
Today’s open172.92
Day’s range169.12 - 173.68
Volume5,112,263
Average volume (3 months)3,232,290
Market cap$131.3B
Dividend yield1.84%
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+10.56%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+7.30%
P/E ratio23.1
Price/Sales6.12
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+2.64+2.33%
BIIBBiogen-6.59-2.06%
BAXBaxter International...+0.41+1.08%
BXLTBaxalta Inc+0.48+1.58%
Data as of 4:03pm ET, 07/29/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)$2.43
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts